Clinical Trial Update: Neoadjuvant Chemoradiation With 5-FU(or Capecitabine) and Oxaliplatin Combined With Hyperthermia in Rectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial investigates neoadjuvant chemoradiation for rectal cancer using 5-FU (or capecitabine) and oxaliplatin with added hyperthermia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• 5-FU (5-fluorouracil)
• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: University of Erlangen-Nürnberg Medical School | Conditions: Rectal Cancer | Phase 1, Phase 2 | Status: UNKNOWN